Home › Funds › Invenomic Capital Management LP › BSX
Invenomic Capital Management LP position in BSX
BOSTON SCIENTIFIC CORP · Health Care
Invenomic Capital Management LP reported holding 389,903 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q3 2026 13F filing — a position valued at US$17.0M, representing 0.84% of its reported portfolio and ranking #42 among its reported holdings. Invenomic Capital Management LP first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Invenomic Capital Management LP's BSX position evolved
Invenomic Capital Management LP first disclosed a stake in BSX in Q3 2026 at 389,903 shares (US$17.0M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 389.90K | $17.02M | New |
About BSX and 13F data
BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 20 other funds we track also report a position in BSX — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$2.56B), MFS Investment Management (US$2.29B), Arrowstreet Capital (US$1.24B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BSX
- PRIMECAP MANAGEMENT CO/CA/ 58.62M sh · $2.56B · Q3 2026
- MFS Investment Management 43.05M sh · $2.29B · Q3 2026
- Arrowstreet Capital 28.47M sh · $1.24B · Q3 2026
- D. E. Shaw & Co 27.27M sh · $1.16B · Q2 2026
- AQR CAPITAL MANAGEMENT LLC 24.32M sh · $1.06B · Q3 2026
- Two Sigma Investments 20.01M sh · $873.30M · Q3 2026
More on Invenomic Capital Management LP
FAQ
How long has Invenomic Capital Management LP held BSX?
Invenomic Capital Management LP has disclosed BSX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Invenomic Capital Management LP's current position in BSX?
As of Q3 2026, Invenomic Capital Management LP holds 389.90K shares of BSX (BOSTON SCIENTIFIC CORP), valued at $17.02M, representing 0.84% of its reported portfolio and ranking #42.
Has Invenomic Capital Management LP been buying or selling BSX?
In the latest 13F filing (Q3 2026), Invenomic Capital Management LP newly opened its position in BSX.
Which other funds hold BSX?
Other major institutional holders of BSX include PRIMECAP MANAGEMENT CO/CA/, MFS Investment Management, Arrowstreet Capital, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.